Quantcast
Home > Quotes > IBB

iShares Nasdaq Biotechnology Index Fund (IBB) Quote & Summary Data

IBB 
$118.22
*  
0.13
0.11%
Get IBB Alerts
*Delayed - data as of Jul. 20, 2018  -  Find a broker to begin trading IBB now
Exchange:NASDAQ

Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
ETF Details
Summary Quote ETF Detail Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
ETF NEWS
ETF Headlines Market Stream
FUNDAMENTALS
Short Interest Dividend History
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 118.75 / $ 117.97
Share Volume
1,741,458
50 Day Avg. Daily Volume
N/A
Previous Close
$ 118.35
52 Week High / Low
$ 119.30 / $ 100.221
Market Cap
9,593,553,000
Annualized Dividend
$ .32
Ex Dividend Date
6/26/2018
Dividend Payment Date
7/2/2018
Current Yield
0.27 %

Intraday Chart

Shares Traded

Share Volume:
1,741,458
50 Day Avg. Daily Volume:
N/A

Trading Range

The current last sale of $118.22 is 17.96% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 118.75 $ 119.30
 Low: $ 117.97 $ 100.221

Nasdaq Official Price

Open Price:
$ 118
Open Date:
Jul. 20, 2018
Close Price:
$ 118.35
Close Date:
Jul. 20, 2018

Description

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index. The Underlying Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by NASDAQ, including minimum market capitalization and liquidity requirements. The Fund generally invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Underlying Index.


Underlying Index NASDAQ Biotechnology Index
Management Fee 0.47
Asset Class equity
Leverage 1
Top Holdings
BIIB BIOGEN INC INC 8.83%
GILD GILEAD SCIENCES INC 8.38%
AMGN AMGEN INC 7.9%
CELG CELGENE CORP 7.38%
ILMN ILLUMINA INC 5.33%
REGN REGENERON PHARMACEUTICALS INC 4.45%
VRTX VERTEX PHARMACEUTICALS INC 4.33%
ALXN ALEXION PHARMACEUTICALS INC 3.68%
MYL MYLAN NV 2.27%
BMRN BIOMARIN PHARMACEUTICAL INC 2.23%

Research Brokers before you trade

Want to trade FX?

Analyst Info